Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Other Non-Current Liabilities (2020 - 2025)

GoHealth's Other Non-Current Liabilities history spans 6 years, with the latest figure at $2.2 million for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 69.75% year-over-year to $2.2 million; the TTM value through Sep 2025 reached $2.2 million, down 69.75%, while the annual FY2024 figure was $9.2 million, 1.15% up from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $2.2 million at GoHealth, down from $2.5 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $9.8 million in Q2 2023 and bottomed at $2.2 million in Q3 2025.
  • The 5-year median for Other Non-Current Liabilities is $6.3 million (2025), against an average of $5.8 million.
  • The largest annual shift saw Other Non-Current Liabilities surged 418.78% in 2021 before it crashed 69.75% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $3.7 million in 2021, then surged by 58.84% to $5.8 million in 2022, then soared by 55.76% to $9.1 million in 2023, then grew by 1.15% to $9.2 million in 2024, then tumbled by 75.79% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Other Non-Current Liabilities are $2.2 million (Q3 2025), $2.5 million (Q2 2025), and $6.3 million (Q1 2025).